A detailed history of Grove Bank & Trust transactions in Abb Vie Inc. stock. As of the latest transaction made, Grove Bank & Trust holds 12,859 shares of ABBV stock, worth $2.16 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
12,859
Previous 16,722 23.1%
Holding current value
$2.16 Million
Previous $2.59 Million 9.65%
% of portfolio
0.4%
Previous 0.48%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$159.82 - $182.1 $617,384 - $703,452
-3,863 Reduced 23.1%
12,859 $2.34 Million
Q4 2023

Jan 30, 2024

BUY
$137.6 - $154.97 $33,849 - $38,122
246 Added 1.49%
16,722 $2.59 Million
Q3 2023

Oct 30, 2023

BUY
$133.59 - $154.65 $98,188 - $113,667
735 Added 4.67%
16,476 $2.46 Million
Q2 2023

Jul 27, 2023

SELL
$132.51 - $164.9 $129,329 - $160,942
-976 Reduced 5.84%
15,741 $2.12 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $37,453 - $43,133
259 Added 1.57%
16,717 $2.66 Million
Q4 2022

Feb 03, 2023

SELL
$138.31 - $165.87 $445,773 - $534,599
-3,223 Reduced 16.38%
16,458 $2.66 Million
Q3 2022

Oct 28, 2022

SELL
$134.21 - $153.93 $225,204 - $258,294
-1,678 Reduced 7.86%
19,681 $2.64 Million
Q2 2022

Jul 29, 2022

SELL
$137.62 - $174.96 $164,455 - $209,077
-1,195 Reduced 5.3%
21,359 $3.27 Million
Q1 2022

Apr 22, 2022

BUY
$131.98 - $163.75 $117,990 - $146,392
894 Added 4.13%
22,554 $3.66 Million
Q4 2021

Jan 31, 2022

SELL
$107.43 - $135.93 $8,916 - $11,282
-83 Reduced 0.38%
21,660 $2.93 Million
Q3 2021

Oct 28, 2021

BUY
$106.4 - $120.78 $19,258 - $21,861
181 Added 0.84%
21,743 $2.35 Million
Q2 2021

Jul 28, 2021

BUY
$105.21 - $117.21 $82,063 - $91,423
780 Added 3.75%
21,562 $2.43 Million
Q1 2021

Apr 23, 2021

BUY
$102.3 - $112.62 $920 - $1,013
9 Added 0.04%
20,782 $2.25 Million
Q4 2020

Feb 03, 2021

BUY
$80.49 - $108.67 $93,448 - $126,165
1,161 Added 5.92%
20,773 $2.23 Million
Q3 2020

Oct 30, 2020

SELL
$85.91 - $100.83 $187,283 - $219,809
-2,180 Reduced 10.0%
19,612 $1.72 Million
Q2 2020

Jul 31, 2020

BUY
$73.37 - $98.18 $161,047 - $215,505
2,195 Added 11.2%
21,792 $2.14 Million
Q1 2020

May 05, 2020

BUY
$64.5 - $97.79 $55,212 - $83,708
856 Added 4.57%
19,597 $1.49 Million
Q4 2019

Feb 11, 2020

BUY
$72.13 - $90.25 $13,055 - $16,335
181 Added 0.98%
18,741 $1.66 Million
Q3 2019

Oct 30, 2019

BUY
$62.98 - $75.72 $81,433 - $97,905
1,293 Added 7.49%
18,560 $1.41 Million
Q2 2019

Jul 24, 2019

BUY
$65.7 - $83.98 $84,096 - $107,494
1,280 Added 8.01%
17,267 $1.26 Million
Q1 2019

Apr 26, 2019

BUY
$77.14 - $90.79 $96,887 - $114,032
1,256 Added 8.53%
15,987 $1.29 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $209,727 - $258,650
-2,694 Reduced 15.46%
14,731 $1.36 Million
Q3 2018

Nov 07, 2018

SELL
$88.91 - $98.84 $61,170 - $68,001
-688 Reduced 3.8%
17,425 $1.65 Million
Q2 2018

Aug 03, 2018

SELL
$89.78 - $106.23 $68,771 - $81,372
-766 Reduced 4.06%
18,113 $1.68 Million
Q1 2018

May 07, 2018

SELL
$92.01 - $123.21 $6,164 - $8,255
-67 Reduced 0.35%
18,879 $1.79 Million
Q4 2017

Feb 02, 2018

SELL
$89.56 - $98.21 $23,016 - $25,239
-257 Reduced 1.34%
18,946 $1.83 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $1.34 Million - $1.71 Million
19,203
19,203 $1.71 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Grove Bank & Trust Portfolio

Follow Grove Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.